{"altmetric_id":22244433,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["kadsho"],"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["316592701707921"],"posts_count":1}},"citation":{"abstract":"Eculizumab, a potent therapy that reduces hemolysis in PNH, carries the risk of invasive meningococcal disease (IMD). It is recommended to vaccinate patients against Neisseria Meningitidis and some centers use prophylactic antibiotics. Following a case of meningococcemia, we investigated cases of breakthrough IMD and we suggest a modified approach.","altmetric_jid":"4f6fa4d23cf058f610000e10","authors":["Eyal Lebel","Uriel Trahtemberg","Colin Block","Orli Zelig","Hila Elinav"],"doi":"10.1016\/j.cmi.2017.07.011","first_seen_on":"2017-07-21T03:39:34+00:00","funders":["niehs"],"handles":[],"issns":["1198-743X","1469-0691"],"journal":"Clinical Microbiology and Infection","last_mentioned_on":1500990336,"links":["http:\/\/www.clinicalmicrobiologyandinfection.com\/article\/S1198-743X(17)30382-8\/fulltext?rss=yes","http:\/\/www.clinicalmicrobiologyandinfection.com\/article\/S1198-743X(17)30382-8\/fulltext"],"pdf_url":"http:\/\/www.clinicalmicrobiologyandinfection.com\/article\/S1198743X17303828\/pdf","pmid":"28736073","pubdate":"2017-07-20T00:00:00+00:00","publisher":"Elsevier","publisher_subjects":[{"name":"Clinical Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["microbiology","communicablediseases"],"title":"Post-eculizumab meningococcaemia in vaccinated patients","type":"article","mendeley_url":"http:\/\/www.mendeley.com\/research\/posteculizumab-meningococcaemia-vaccinated-patients"},"altmetric_score":{"score":0.5,"score_history":{"1y":0.5,"6m":0.5,"3m":0.5,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.5},"context_for_score":{"all":{"total_number_of_other_articles":8272105,"mean":6.9807941447478,"rank":6275925,"this_scored_higher_than_pct":13,"this_scored_higher_than":1118301,"rank_type":"exact","sample_size":8272105,"percentile":13},"similar_age_3m":{"total_number_of_other_articles":178902,"mean":11.674558141095,"rank":126165,"this_scored_higher_than_pct":18,"this_scored_higher_than":32770,"rank_type":"exact","sample_size":178902,"percentile":18},"this_journal":{"total_number_of_other_articles":1710,"mean":4.4204493856056,"rank":1246,"this_scored_higher_than_pct":14,"this_scored_higher_than":251,"rank_type":"exact","sample_size":1710,"percentile":14},"similar_age_this_journal_3m":{"total_number_of_other_articles":68,"mean":8.4164179104478,"rank":56,"this_scored_higher_than_pct":7,"this_scored_higher_than":5,"rank_type":"exact","sample_size":68,"percentile":7}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Researcher":1,"Student  > Postgraduate":1,"Student  > Master":1,"Other":1},"by_discipline":{"Medicine and Dentistry":1,"Unspecified":1,"Pharmacology, Toxicology and Pharmaceutical Science":2}}},"geo":{"twitter":{"JP":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/kadsho\/statuses\/888241954898665472","license":"gnip","citation_ids":[22244433],"posted_on":"2017-07-21T03:39:19+00:00","author":{"name":"\u9580\u6751\u5c06\u592a Hosp Pharmacist","image":"https:\/\/pbs.twimg.com\/profile_images\/778806726757748737\/QcGpyRcy_normal.jpg","description":"PIC(JSHP)\/IDCP(JSC)\/CNP(JSNP)\/\u85ac\u7269\u7642\u6cd5\u5c02\u9580\u85ac\u5264\u5e2b(JSPHCS) #PharmaceuticalCare, #ClinicalPharmacy, #DI, #Pharmacoepidemiology, #EBM, #AntimicrobialStewardship #ASP","id_on_source":"kadsho","tweeter_id":"168488514","geo":{"lt":43.06417,"ln":141.34694,"country":"JP"},"followers":2130},"tweet_id":"888241954898665472"}],"facebook":[{"title":"Post-eculizumab meningococcaemia in vaccinated patients","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=1594595713907607&id=316592701707921","license":"public","citation_ids":[22244433],"posted_on":"2017-07-25T13:45:36+00:00","summary":"Lebel et al report a case of a patient treated with eculizumab who developed meningococcaemia\nhttp:\/\/www.clinicalmicrobiologyandinfection.com\/article\/S1198-743X(17)30382-8\/fulltext","author":{"name":"ESCMID","url":"https:\/\/www.facebook.com\/316592701707921","facebook_wall_name":"ESCMID","image":"https:\/\/graph.facebook.com\/316592701707921\/picture","id_on_source":"316592701707921"}}]}}